{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T15:10:17Z","timestamp":1788707417830,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key R&D Program of Gansu Province","award":["24YFWA010"],"award-info":[{"award-number":["24YFWA010"]}]},{"name":"the High-level Key Research Project of Gansu Provincial Administration of Traditional Chinese Medicine","award":["GZKZ-2025-52"],"award-info":[{"award-number":["GZKZ-2025-52"]}]},{"name":"the Science and Technology Program Project of Lanzhou Municipal Bureau of Science and Technology","award":["2025-2-206"],"award-info":[{"award-number":["2025-2-206"]}]},{"name":"the Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2024-MS-A15"],"award-info":[{"award-number":["CY2024-MS-A15"]}]},{"name":"the Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2024-MS-B17"],"award-info":[{"award-number":["CY2024-MS-B17"]}]},{"name":"the Talent Innovation and Entrepreneurship Project of Lanzhou City","award":["2020-RC-43"],"award-info":[{"award-number":["2020-RC-43"]}]},{"name":"Gansu Provincial Medical Products Administration Project","award":["No.2025GSMPA-KL01"],"award-info":[{"award-number":["No.2025GSMPA-KL01"]}]},{"name":"Gansu Provincial Medical Products Administration Project","award":["2025GSMPA068"],"award-info":[{"award-number":["2025GSMPA068"]}]},{"name":"Science and Technology Major Program of Gansu Province of China","award":["23ZDFA015"],"award-info":[{"award-number":["23ZDFA015"]}]},{"name":"Science and Technology Major Program of Gansu Province of China","award":["24ZD13FA017"],"award-info":[{"award-number":["24ZD13FA017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04483-6","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T14:56:26Z","timestamp":1788706586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer risk and mortality assessment in the overweight population: evaluation of single and integrated models based on inflammatory markers"],"prefix":"10.1007","author":[{"given":"Xiangji","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8581-2571","authenticated-orcid":false,"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"4483_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"4483_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/s0140-6736(14)60892-8","volume":"384","author":"K Bhaskaran","year":"2014","unstructured":"Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5\u00b724 million UK adults. Lancet. 2014;384:755\u201365. https:\/\/doi.org\/10.1016\/s0140-6736(14)60892-8.","journal-title":"Lancet"},{"key":"4483_CR3","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381:2440\u201350. https:\/\/doi.org\/10.1056\/NEJMsa1909301.","journal-title":"N Engl J Med"},{"key":"4483_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10654-014-9973-5","volume":"30","author":"XM Liu","year":"2015","unstructured":"Liu XM, Liu YJ, Zhan J, He QQ. Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2015;30:35\u201345. https:\/\/doi.org\/10.1007\/s10654-014-9973-5.","journal-title":"Eur J Epidemiol"},{"key":"4483_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.3520","volume":"4","author":"F Petrelli","year":"2021","unstructured":"Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O, et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw Open. 2021;4:e213520. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.3520.","journal-title":"JAMA Netw Open"},{"key":"4483_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228633","volume":"15","author":"I Elisia","year":"2020","unstructured":"Elisia I, Lam V, Cho B, Hay M, Li MY, Kapeluto J, et al. Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk. PLoS ONE. 2020;15:e0228633. https:\/\/doi.org\/10.1371\/journal.pone.0228633.","journal-title":"PLoS ONE"},{"key":"4483_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2147\/jir.S294368","volume":"14","author":"E Cohen","year":"2021","unstructured":"Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. Markers of chronic inflammation in overweight and obese individuals and the role of gender: a cross-sectional study of a large cohort. J Inflamm Res. 2021;14:567\u201373. https:\/\/doi.org\/10.2147\/jir.S294368.","journal-title":"J Inflamm Res"},{"key":"4483_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2412872121","volume":"121","author":"A Pandey","year":"2024","unstructured":"Pandey A, Ye Y, Wells CR, Singer BH, Galvani AP. Estimating the lives that could be saved by expanded access to weight-loss drugs. Proc Natl Acad Sci USA. 2024;121:e2412872121. https:\/\/doi.org\/10.1073\/pnas.2412872121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4483_CR9","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1158\/0008-5472.Can-22-1257","volume":"82","author":"A Singh","year":"2022","unstructured":"Singh A, Mayengbam SS, Yaduvanshi H, Wani MR, Bhat MK. Obesity programs macrophages to support cancer progression. Cancer Res. 2022;82:4303\u201312. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-1257.","journal-title":"Cancer Res"},{"key":"4483_CR10","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1007\/s00018-020-03752-z","volume":"78","author":"A Kulkarni","year":"2021","unstructured":"Kulkarni A, Bowers LW. The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis. Cell Mol Life Sci. 2021;78:3423\u201342. https:\/\/doi.org\/10.1007\/s00018-020-03752-z.","journal-title":"Cell Mol Life Sci"},{"key":"4483_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111045","volume":"27","author":"T Lan","year":"2024","unstructured":"Lan T, Lu Y, He J, Zhan C, Wang X, Shao X, et al. Global, reginal, national burden and risk factors in female breast cancer from 1990 to 2021. iScience. 2024;27:111045. https:\/\/doi.org\/10.1016\/j.isci.2024.111045.","journal-title":"iScience"},{"key":"4483_CR12","volume-title":"StatPearls","author":"CB Weir","year":"2025","unstructured":"Weir CB, Jan A. Obesity and cancer risk. In: StatPearls. Treasure Island: StatPearls Publishing LLC; 2025."},{"key":"4483_CR13","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1210\/clinem\/dgac241","volume":"107","author":"SC Naaman","year":"2022","unstructured":"Naaman SC, Shen S, Zeytinoglu M, Iyengar NM. Obesity and breast cancer risk: the oncogenic implications of metabolic dysregulation. J Clin Endocrinol Metab. 2022;107:2154\u201366. https:\/\/doi.org\/10.1210\/clinem\/dgac241.","journal-title":"J Clin Endocrinol Metab"},{"key":"4483_CR14","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.3390\/cancers15102778","volume":"15","author":"N Azizi","year":"2023","unstructured":"Azizi N, Zangiabadian M, Seifi G, Davari A, Yekekhani E, Safavi-Naini SAA, et al. Gastric cancer risk in association with underweight, overweight, and obesity: a systematic review and meta-analysis. Cancers. 2023;15:2778. https:\/\/doi.org\/10.3390\/cancers15102778.","journal-title":"Cancers"},{"key":"4483_CR15","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1158\/0008-5472.Can-17-3043","volume":"78","author":"Y Park","year":"2018","unstructured":"Park Y, Peterson LL, Colditz GA. The plausibility of obesity paradox in cancer-point. Cancer Res. 2018;78:1898\u2013903. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-3043.","journal-title":"Cancer Res"},{"key":"4483_CR16","doi-asserted-by":"publisher","first-page":"1448012","DOI":"10.3389\/fimmu.2024.1448012","volume":"15","author":"C Liang","year":"2024","unstructured":"Liang C, Kan J, Wang J, Lu W, Mo X, Zhang B. Nasopharyngeal carcinoma-associated inflammatory cytokines: ongoing biomarkers. Front Immunol. 2024;15:1448012. https:\/\/doi.org\/10.3389\/fimmu.2024.1448012.","journal-title":"Front Immunol"},{"key":"4483_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","volume":"36","author":"TH N\u00f8st","year":"2021","unstructured":"N\u00f8st TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, et al. Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 2021;36:841\u20138. https:\/\/doi.org\/10.1007\/s10654-021-00752-6.","journal-title":"Eur J Epidemiol"},{"key":"4483_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3332\/ecancer.2017.721","volume":"11","author":"TG Shrihari","year":"2017","unstructured":"Shrihari TG. Dual role of inflammatory mediators in cancer. Ecancermedicalscience. 2017;11:721. https:\/\/doi.org\/10.3332\/ecancer.2017.721.","journal-title":"Ecancermedicalscience"},{"key":"4483_CR19","doi-asserted-by":"publisher","first-page":"2939162","DOI":"10.1155\/2021\/2939162","volume":"2021","author":"YX Li","year":"2021","unstructured":"Li YX, Chang JY, He MY, Wang HR, Luo DQ, Li FH, et al. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) predict clinical outcome in patients with stage IIB cervical cancer. J Oncol. 2021;2021:2939162. https:\/\/doi.org\/10.1155\/2021\/2939162.","journal-title":"J Oncol"},{"key":"4483_CR20","doi-asserted-by":"publisher","first-page":"2337729","DOI":"10.1080\/07853890.2024.2337729","volume":"56","author":"S Zhang","year":"2024","unstructured":"Zhang S, Cheng T. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis. Ann Med. 2024;56:2337729. https:\/\/doi.org\/10.1080\/07853890.2024.2337729.","journal-title":"Ann Med"},{"key":"4483_CR21","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.62347\/mukd2745","volume":"14","author":"YL Li","year":"2024","unstructured":"Li YL, Chen CH, Lai YS, Pan MR, Hung WC. Increased blood CSF3R(+) myeloid-derived suppressor cell is a predictor for breast cancer recurrence. Am J Cancer Res. 2024;14:3171\u201385. https:\/\/doi.org\/10.62347\/mukd2745.","journal-title":"Am J Cancer Res"},{"key":"4483_CR22","doi-asserted-by":"publisher","first-page":"19673","DOI":"10.1038\/s41598-019-56218-z","volume":"9","author":"R Howard","year":"2019","unstructured":"Howard R, Kanetsky PA, Egan KM. Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer. Sci Rep. 2019;9:19673. https:\/\/doi.org\/10.1038\/s41598-019-56218-z.","journal-title":"Sci Rep"},{"key":"4483_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12916-020-01848-8","volume":"19","author":"S Parra-Soto","year":"2021","unstructured":"Parra-Soto S, Cowley ES, Rezende LFM, Ferreccio C, Mathers JC, Pell JP, et al. Associations of six adiposity-related markers with incidence and mortality from 24 cancers-findings from the UK Biobank prospective cohort study. BMC Med. 2021;19:7. https:\/\/doi.org\/10.1186\/s12916-020-01848-8.","journal-title":"BMC Med"},{"key":"4483_CR24","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2217\/fon-2020-0423","volume":"16","author":"A Li","year":"2020","unstructured":"Li A, Mu X, He K, Wang P, Wang D, Liu C, et al. Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases. Future Oncol. 2020;16:2433\u201344. https:\/\/doi.org\/10.2217\/fon-2020-0423.","journal-title":"Future Oncol"},{"key":"4483_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.774823","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li Z, Huang Z, Yu X, Zheng L, Xu J. C-reactive protein is an indicator of the immunosuppressive microenvironment fostered by myeloid cells in hepatocellular carcinoma. Front Oncol. 2021;11:774823. https:\/\/doi.org\/10.3389\/fonc.2021.774823.","journal-title":"Front Oncol"},{"key":"4483_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/ajcn\/nqaa335","volume":"113","author":"S Parra-Soto","year":"2021","unstructured":"Parra-Soto S, Petermann-Rocha F, Boonpor J, Gray SR, Pell JP, Celis-Morales C, et al. Combined association of general and central obesity with incidence and mortality of cancers in 22 sites. Am J Clin Nutr. 2021;113:401\u20139. https:\/\/doi.org\/10.1093\/ajcn\/nqaa335.","journal-title":"Am J Clin Nutr"},{"key":"4483_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12916-024-03544-27","volume":"22","author":"EM Gonz\u00e1lez-Gil","year":"2024","unstructured":"Gonz\u00e1lez-Gil EM, Peruchet-Noray L, Sedlmeier AM, Christakoudi S, Biessy C, Navionis AS, et al. Association of body shape phenotypes and body fat distribution indexes with inflammatory biomarkers in the European prospective investigation into cancer and nutrition (EPIC) and UK Biobank. BMC Med. 2024;22:334. https:\/\/doi.org\/10.1186\/s12916-024-03544-27.","journal-title":"BMC Med"},{"key":"4483_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1337241","volume":"15","author":"K Liu","year":"2024","unstructured":"Liu K, Tang S, Liu C, Ma J, Cao X, Yang X, et al. Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Front Immunol. 2024;15:1337241. https:\/\/doi.org\/10.3389\/fimmu.2024.1337241.","journal-title":"Front Immunol"},{"key":"4483_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1459740","volume":"15","author":"N Lu","year":"2024","unstructured":"Lu N, Sheng S, Xiong Y, Zhao C, Qiao W, Ding X, et al. Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study. Front Immunol. 2024;15:1459740. https:\/\/doi.org\/10.3389\/fimmu.2024.1459740.","journal-title":"Front Immunol"},{"key":"4483_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1440742","volume":"14","author":"M Zhang","year":"2024","unstructured":"Zhang M, Mo J, Huang W, Bao Y, Luo X, Yuan L. The ovarian cancer-associated microbiome contributes to the tumor\u2019s inflammatory microenvironment. Front Cell Infect Microbiol. 2024;14:1440742. https:\/\/doi.org\/10.3389\/fcimb.2024.1440742.","journal-title":"Front Cell Infect Microbiol"},{"key":"4483_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1275033","volume":"14","author":"J Zheng","year":"2023","unstructured":"Zheng J, Peng L, Zhang S, Liao H, Hao J, Wu S, et al. Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma. Front Immunol. 2023;14:1275033. https:\/\/doi.org\/10.3389\/fimmu.2023.1275033.","journal-title":"Front Immunol"},{"key":"4483_CR32","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","volume":"23","author":"JH Chen","year":"2017","unstructured":"Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23:6261\u201372. https:\/\/doi.org\/10.3748\/wjg.v23.i34.6261.","journal-title":"World J Gastroenterol"},{"key":"4483_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5903-y","volume":"19","author":"T Hirahara","year":"2019","unstructured":"Hirahara T, Arigami T, Yanagita S, Matsushita D, Uchikado Y, Kita Y, et al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. BMC Cancer. 2019;19:672. https:\/\/doi.org\/10.1186\/s12885-019-5903-y.","journal-title":"BMC Cancer"},{"key":"4483_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.791912","volume":"11","author":"P Ding","year":"2021","unstructured":"Ding P, Yang P, Sun C, Tian Y, Guo H, Liu Y, et al. Predictive effect of systemic immune-inflammation index combined with prognostic nutrition index score on efficacy and prognosis of neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib conversion therapy in gastric cancer patients with positive peritoneal lavage cytology: a prospective study. Front Oncol. 2021;11:791912. https:\/\/doi.org\/10.3389\/fonc.2021.791912.","journal-title":"Front Oncol"},{"key":"4483_CR35","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/aog.0000000000000643","volume":"125","author":"RE Bristow","year":"2015","unstructured":"Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol. 2015;125:833\u201342. https:\/\/doi.org\/10.1097\/aog.0000000000000643.","journal-title":"Obstet Gynecol"},{"key":"4483_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218048","volume":"14","author":"N Karavasiloglou","year":"2019","unstructured":"Karavasiloglou N, Pestoni G, Wanner M, Faeh D, Rohrmann S. Healthy lifestyle is inversely associated with mortality in cancer survivors: results from the Third National Health and Nutrition Examination Survey (NHANES III). PLoS ONE. 2019;14:e0218048. https:\/\/doi.org\/10.1371\/journal.pone.0218048.","journal-title":"PLoS ONE"},{"key":"4483_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/ijgc-2021-003323","volume":"32","author":"AS Frost","year":"2022","unstructured":"Frost AS, Smith AJB, Fader AN, Wethington SL. Modifiable risk factors associated with long-term survival in women with serous ovarian cancer: a National Cancer Database study. Int J Gynecol Cancer. 2022;32:769\u201380. https:\/\/doi.org\/10.1136\/ijgc-2021-003323.","journal-title":"Int J Gynecol Cancer"},{"key":"4483_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0630-7","volume":"19","author":"NC Brownstein","year":"2019","unstructured":"Brownstein NC, Cai J. Tests of trend between disease outcomes and ordinal covariates discretized from underlying continuous variables: simulation studies and applications to NHANES 2007-2008. BMC Med Res Methodol. 2019;19:2. https:\/\/doi.org\/10.1186\/s12874-018-0630-7.","journal-title":"BMC Med Res Methodol"},{"key":"4483_CR39","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/j.ajkd.2007.12.012","volume":"51","author":"MV Rao","year":"2008","unstructured":"Rao MV, Qiu Y, Wang C, Bakris G. Hypertension and CKD: kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES), 1999\u20132004. Am J Kidney Dis. 2008;51:S30-37. https:\/\/doi.org\/10.1053\/j.ajkd.2007.12.012.","journal-title":"Am J Kidney Dis"},{"key":"4483_CR40","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1053\/j.ajkd.2007.12.016","volume":"51","author":"AT Whaley-Connell","year":"2008","unstructured":"Whaley-Connell AT, Sowers JR, Stevens LA, McFarlane SI, Shlipak MG, Norris KC, et al. CKD in the United States: kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES) 1999\u20132004. Am J Kidney Dis. 2008;51:S13-20. https:\/\/doi.org\/10.1053\/j.ajkd.2007.12.016.","journal-title":"Am J Kidney Dis"},{"key":"4483_CR41","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000209807","volume":"103","author":"S Hassani","year":"2024","unstructured":"Hassani S, Ovbiagele B, Markovic D, Towfighi A. Association between abnormal sleep duration and stroke in the United States. Neurology. 2024;103:e209807. https:\/\/doi.org\/10.1212\/wnl.0000000000209807.","journal-title":"Neurology"},{"key":"4483_CR42","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72:558\u201369. https:\/\/doi.org\/10.4097\/kja.19087.","journal-title":"Korean J Anesthesiol"},{"key":"4483_CR43","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.athoracsur.2019.09.049","volume":"109","author":"A Kilic","year":"2020","unstructured":"Kilic A, Goyal A, Miller JK, Gjekmarkaj E, Tam WL, Gleason TG, et al. Predictive utility of a machine learning algorithm in estimating mortality risk in cardiac surgery. Ann Thorac Surg. 2020;109:1811\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2019.09.049.","journal-title":"Ann Thorac Surg"},{"key":"4483_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1207235","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang L, Du W, Huang Y, Guo Y, Song C, et al. Identification of high-risk factors associated with mortality at 1-, 3-, and 5-year intervals in gastric cancer patients undergoing radical surgery and immunotherapy: an 8-year multicenter retrospective analysis. Front Cell Infect Microbiol. 2023;13:1207235. https:\/\/doi.org\/10.3389\/fcimb.2023.1207235.","journal-title":"Front Cell Infect Microbiol"},{"key":"4483_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010037","volume":"17","author":"MM Midik","year":"2024","unstructured":"Midik MM, Gunenc D, Acar PF, Karaca BS. Prognostic value of blood-based inflammatory markers in cancer patients receiving immune checkpoint inhibitors. Cancers (Basel). 2024;17:37. https:\/\/doi.org\/10.3390\/cancers17010037.","journal-title":"Cancers (Basel)"},{"key":"4483_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00766","volume":"10","author":"B Chao","year":"2020","unstructured":"Chao B, Ju X, Zhang L, Xu X, Zhao Y. A novel prognostic marker systemic inflammation response index (SIRI) for operable cervical cancer patients. Front Oncol. 2020;10:766. https:\/\/doi.org\/10.3389\/fonc.2020.00766.","journal-title":"Front Oncol"},{"key":"4483_CR47","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3892\/or.2019.7344","volume":"42","author":"G An","year":"2019","unstructured":"An G, Wu F, Huang S, Feng L, Bai J, Gu S, et al. Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor\u2011associated macrophages. Oncol Rep. 2019;42:2499\u2013511. https:\/\/doi.org\/10.3892\/or.2019.7344.","journal-title":"Oncol Rep"},{"key":"4483_CR48","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670\u201391. https:\/\/doi.org\/10.1016\/j.cell.2016.11.037.","journal-title":"Cell"},{"key":"4483_CR49","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1248\/bpb.30.2001","volume":"30","author":"Y Ohsugi","year":"2007","unstructured":"Ohsugi Y. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases. Biol Pharm Bull. 2007;30:2001\u20136. https:\/\/doi.org\/10.1248\/bpb.30.2001.","journal-title":"Biol Pharm Bull"},{"key":"4483_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024;8:31. https:\/\/doi.org\/10.1038\/s41698-024-00522-z.","journal-title":"NPJ Precis Oncol"},{"key":"4483_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40164-021-00252-z","volume":"10","author":"S Zhu","year":"2021","unstructured":"Zhu S, Yi M, Wu Y, Dong B, Wu K. Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies. Exp Hematol Oncol. 2021;10:60. https:\/\/doi.org\/10.1186\/s40164-021-00252-z.","journal-title":"Exp Hematol Oncol"},{"key":"4483_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402678","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li S, Xiao Y, Liu X, Zhang B, Zeng Q, et al. A multi-functional nanoadjuvant coupling manganese with toll-like 9 agonist stimulates potent innate and adaptive anti-tumor immunity. Adv Sci (Weinh). 2024;11:e2402678. https:\/\/doi.org\/10.1002\/advs.202402678.","journal-title":"Adv Sci (Weinh)"},{"key":"4483_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, He L, Zhu J, Zhang P, Liang S. Targeting tumor-associated macrophages for cancer treatment. Cell Biosci. 2022;12:85. https:\/\/doi.org\/10.1186\/s13578-022-00823-5.","journal-title":"Cell Biosci"},{"key":"4483_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131787","volume":"12","author":"A Benoit","year":"2023","unstructured":"Benoit A, Vogin G, Duhem C, Berchem G, Janji B. Lighting up the fire in the microenvironment of cold tumors: a major challenge to improve cancer immunotherapy. Cells. 2023;12:1787. https:\/\/doi.org\/10.3390\/cells12131787.","journal-title":"Cells"},{"key":"4483_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2018.08.025","volume":"437","author":"S Lee","year":"2018","unstructured":"Lee S, Lee E, Ko E, Ham M, Lee HM, Kim ES, et al. Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-\u03b1 and MMP-9. Cancer Lett. 2018;437:25\u201334. https:\/\/doi.org\/10.1016\/j.canlet.2018.08.025.","journal-title":"Cancer Lett"},{"key":"4483_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-62658-7_1","volume":"1302","author":"T O'Connor","year":"2021","unstructured":"O\u2019Connor T, Heikenwalder M. CCL2 in the tumor microenvironment. Adv Exp Med Biol. 2021;1302:1\u201314. https:\/\/doi.org\/10.1007\/978-3-030-62658-7_1.","journal-title":"Adv Exp Med Biol"},{"key":"4483_CR57","doi-asserted-by":"publisher","first-page":"23494","DOI":"10.1038\/s41598-024-74247-1","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Yang H, Qi Y, Yu P, Han X, Zhang Z, et al. CISD3 is a prognostic biomarker and therapeutic target in pan-cancer. Sci Rep. 2024;14:23494. https:\/\/doi.org\/10.1038\/s41598-024-74247-1.","journal-title":"Sci Rep"},{"key":"4483_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111863","volume":"131","author":"ZY Wang","year":"2024","unstructured":"Wang ZY, Xu B, Wang LN, Zhu XD, Huang C, Shen YH, et al. Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapies. Int Immunopharmacol. 2024;131:111863. https:\/\/doi.org\/10.1016\/j.intimp.2024.111863.","journal-title":"Int Immunopharmacol"},{"key":"4483_CR59","doi-asserted-by":"publisher","first-page":"1482746","DOI":"10.3389\/fimmu.2024.1482746","volume":"15","author":"Y Ou","year":"2024","unstructured":"Ou Y, Liang S, Gao Q, Shang Y, Liang J, Zhang W, et al. Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Front Immunol. 2024;15:1482746. https:\/\/doi.org\/10.3389\/fimmu.2024.1482746.","journal-title":"Front Immunol"},{"key":"4483_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000013585","volume":"97","author":"X Zhang","year":"2018","unstructured":"Zhang X, Jiang Y, Wang Y, Wang Z, Zhao L, Xue X, et al. Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e13585. https:\/\/doi.org\/10.1097\/md.0000000000013585.","journal-title":"Medicine (Baltimore)"},{"key":"4483_CR61","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/medicina58081069","volume":"58","author":"H Platini","year":"2022","unstructured":"Platini H, Ferdinand E, Kohar K, Prayogo SA, Amirah S, Komariah, Maulana S. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as prognostic markers for advanced non-small-cell lung cancer treated with immunotherapy: a systematic review and meta-analysis. Medicina (Kaunas). 2022;58:1069. https:\/\/doi.org\/10.3390\/medicina58081069.","journal-title":"Medicina (Kaunas)"},{"key":"4483_CR62","doi-asserted-by":"publisher","first-page":"1032907","DOI":"10.3389\/fimmu.2022.1032907","volume":"13","author":"P Liu","year":"2022","unstructured":"Liu P, Chen S, Gao X, Liang H, Sun D, Shi B, et al. Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer. Front Immunol. 2022;13:1032907. https:\/\/doi.org\/10.3389\/fimmu.2022.1032907.","journal-title":"Front Immunol"},{"key":"4483_CR63","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","volume":"122","author":"Q Qi","year":"2016","unstructured":"Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122:2158\u201367. https:\/\/doi.org\/10.1002\/cncr.30057.","journal-title":"Cancer"},{"key":"4483_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22964","volume":"33","author":"J Liu","year":"2019","unstructured":"Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal. 2019;33:e22964. https:\/\/doi.org\/10.1002\/jcla.22964.","journal-title":"J Clin Lab Anal"},{"key":"4483_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.350","volume":"4","author":"K Liao","year":"2023","unstructured":"Liao K, Zhang X, Liu J, Teng F, He Y, Cheng J, et al. The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy. MedComm. 2023;4:e350. https:\/\/doi.org\/10.1002\/mco2.350.","journal-title":"MedComm"},{"key":"4483_CR66","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2147\/cmar.S461964","volume":"16","author":"S Ma","year":"2024","unstructured":"Ma S, Li F, Wang L. The construction of a nomogram using the pan-immune-inflammation value combined with a PILE score for immunotherapy prediction prognosis in advanced NSCLC. Cancer Manag Res. 2024;16:741\u201351. https:\/\/doi.org\/10.2147\/cmar.S461964.","journal-title":"Cancer Manag Res"},{"key":"4483_CR67","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00262-016-1931-5","volume":"66","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Li M, Bo C, Liu X, Zhang J, Li Z, et al. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma. Cancer Immunol Immunother. 2017;66:343\u201354. https:\/\/doi.org\/10.1007\/s00262-016-1931-5.","journal-title":"Cancer Immunol Immunother"},{"key":"4483_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8628540","volume":"2020","author":"E Topkan","year":"2020","unstructured":"Topkan E, Kucuk A, Ozdemir Y, Mertsoylu H, Besen AA, Sezen D, et al. Systemic inflammation response index predicts survival outcomes in glioblastoma multiforme patients treated with standard Stupp protocol. J Immunol Res. 2020;2020:8628540. https:\/\/doi.org\/10.1155\/2020\/8628540.","journal-title":"J Immunol Res"},{"key":"4483_CR69","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.1038\/s41598-025-98408-y","volume":"15","author":"Z Yang","year":"2025","unstructured":"Yang Z, Li Y, Guo T, Yang M, Chen Y, Gao Y. The effect of inflammatory markers on mortality in patients with acute myocardial infarction. Sci Rep. 2025;15:14514. https:\/\/doi.org\/10.1038\/s41598-025-98408-y.","journal-title":"Sci Rep"},{"key":"4483_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1136198","volume":"13","author":"Z Tian","year":"2023","unstructured":"Tian Z, Li C, Wang X, Sun H, Zhang P, Yu Z. Prediction of bone metastasis risk of early breast cancer based on nomogram of clinicopathological characteristics and hematological parameters. Front Oncol. 2023;13:1136198. https:\/\/doi.org\/10.3389\/fonc.2023.1136198.","journal-title":"Front Oncol"},{"key":"4483_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073352","volume":"26","author":"S Kawanishi","year":"2025","unstructured":"Kawanishi S, Wang G, Ma N, Murata M. Cancer development and progression through a vicious cycle of DNA damage and inflammation. Int J Mol Sci. 2025;26:3352. https:\/\/doi.org\/10.3390\/ijms26073352.","journal-title":"Int J Mol Sci"},{"key":"4483_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.70050","volume":"43","author":"P Kumar","year":"2025","unstructured":"Kumar P, Kumar A, Kumar V. Role of microbiota-derived metabolites in prostate cancer inflammation and progression. Cell Biochem Funct. 2025;43:e70050. https:\/\/doi.org\/10.1002\/cbf.70050.","journal-title":"Cell Biochem Funct"},{"key":"4483_CR73","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1093\/eurheartj\/ehz587","volume":"40","author":"CC Van't Klooster","year":"2019","unstructured":"Van't Klooster CC, Ridker PM, Hjortnaes J, van der Graaf Y, Asselbergs FW, Westerink J, et al. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J. 2019;40:3901\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehz587.","journal-title":"Eur Heart J"},{"key":"4483_CR74","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/biology13050352","volume":"13","author":"E Vitale","year":"2024","unstructured":"Vitale E, Rizzo A, Santa K, Jirillo E. Associations between \u201cCancer Risk\u201d, \u201cInflammation\u201d and \u201cMetabolic Syndrome\u201d: a scoping review. Biology (Basel). 2024;13:352. https:\/\/doi.org\/10.3390\/biology13050352.","journal-title":"Biology (Basel)"},{"key":"4483_CR75","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12889-025-21423-1","volume":"25","author":"S Wu","year":"2025","unstructured":"Wu S, Liu Z, Li X, Gao S, Xia P. Association between systemic immune-inflammation index and the risk of all-cause, cancer and non-cancer mortality in the general population: results from national health and nutrition examination survey 2005\u20132018. BMC Public Health. 2025;25:227. https:\/\/doi.org\/10.1186\/s12889-025-21423-1.","journal-title":"BMC Public Health"},{"key":"4483_CR76","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s10237-024-01891-x","volume":"23","author":"SMA Mortazavi","year":"2024","unstructured":"Mortazavi SMA, Firoozabadi B. Towards a framework for predicting immunotherapy outcome: a hybrid multiscale mathematical model of immune response to vascular tumor growth. Biomech Model Mechanobiol. 2024;23:2243\u201364. https:\/\/doi.org\/10.1007\/s10237-024-01891-x.","journal-title":"Biomech Model Mechanobiol"},{"key":"4483_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604464","volume":"11","author":"JY Humrich","year":"2020","unstructured":"Humrich JY, Bernardes JP, Ludwig RJ, Klatzmann D, Scheffold A. Phenotyping of adaptive immune responses in inflammatory diseases. Front Immunol. 2020;11:604464. https:\/\/doi.org\/10.3389\/fimmu.2020.604464.","journal-title":"Front Immunol"},{"key":"4483_CR78","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/cancers14071622","volume":"14","author":"F Guerville","year":"2022","unstructured":"Guerville F, Bourdel-Marchasson I, D\u00e9chanet-Merville J, Pellegrin I, Soubeyran P, Appay V, et al. Does inflammation contribute to cancer incidence and mortality during aging a conceptual review. Cancers (Basel). 2022;14:1622. https:\/\/doi.org\/10.3390\/cancers14071622.","journal-title":"Cancers (Basel)"},{"key":"4483_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1372731","volume":"12","author":"L Wang","year":"2024","unstructured":"Wang L, Li X, Liu M, Zhou H, Shao J. Association between monocyte-to-lymphocyte ratio and prostate cancer in the U.S. population: a population-based study. Front Cell Dev Biol. 2024;12:1372731. https:\/\/doi.org\/10.3389\/fcell.2024.1372731.","journal-title":"Front Cell Dev Biol"},{"key":"4483_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-024-00796-w","author":"CE Thomas","year":"2024","unstructured":"Thomas CE, Peters U. Genomic landscape of cancer in racially and ethnically diverse populations. Nat Rev Genet. 2024. https:\/\/doi.org\/10.1038\/s41576-024-00796-w.","journal-title":"Nat Rev Genet"},{"key":"4483_CR81","doi-asserted-by":"publisher","DOI":"10.31083\/CEOG33516","volume":"52","author":"R Sener","year":"2025","unstructured":"Sener R, Ozbilge S, Akkus F, Serin EC, G\u00fcnenc O. Neutrophil percentage-to-albumin ratio in the diagnosis of ovarian torsion-predictive role. Clin Exp Obstet Gynecol. 2025;52:33516. https:\/\/doi.org\/10.31083\/CEOG33516.","journal-title":"Clin Exp Obstet Gynecol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04483-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04483-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04483-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T14:56:28Z","timestamp":1788706588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04483-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":81,"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04483-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey protocol was approved by the Research Ethics Review Board of the National Center for Health Statistics (\n                      \n                      . gov\/nchs\/nhanes\/irba98.htm). The NCHS Research Ethics Review Board reviewed and approved the NHANES, and all survey participants provided written informed consent. Therefore, no further ethical approval or informed consent was needed.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}